Relevium Launches Pre-Order of Bioganix® Cleancare Hand Sanitizers
07 April 2020 - 1:03AM
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to
announce today that a pre-order platform where customers can
purchase in advance and reserve its new line of Cleancare hand
sanitizers by Bioganix ®.
The Company will begin accepting pre-orders for
the company’s new Cleancare hand sanitizer products and will be
shipped out to customers on a first come first serve basis. The
company expects the product to be available eight weeks from now
and expect this format to be in high demand. The Company will
prioritize existing customers in the United States.
The company will begin its initial pre-order
with approximately 10,000 units and will actively scale up
operations to meet market demand. The company will also begin on
formulating new formats of Cleancare products including 2oz travel
size as well it is working on launching new technologies for the
home care market.
In addition to launching the company’s new hand
sanitizer product, the company has also pledged to donate Bioganix®
Cleancare products to local shelters, institutions and support
centers in Montreal, where the company’s headquarters reside.
“Our products will be offered initially to our
existing customer base and we expect to be able to offer the
product to all new customers thereafter” stated Aurelio Useche, CEO
of Relevium. “Montreal is currently the hardest hit city in Canada,
and we are pleased to be able to secure a percentage of our supply
to support our local government’s efforts to manage the current
outbreak”
About Relevium Technologies
Relevium is a publicly traded Company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe. Relevium’s premium brands are sold
at some of the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical Company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Cautionary Note Regarding
Forward-Looking Statements
This release includes certain statements and
information that may constitute forward-looking information within
the meaning of applicable Canadian and United States securities
laws. All statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, assumptions or expectations of future
performance, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", or "would" occur.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES
INCEmail: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on FacebookFollow us on
Twitter Follow us on LinkedIn
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e9531eaa-9c71-48e3-b924-48238025322d
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024